UNPLANNED REPRESENTATION TO HOSPITAL BY PATIENTS WITH DIABETES: DEVELOPMENT AND PILOT FEASIBILITY TESTING OF A SCREENING TOOL

2022 ◽  
pp. 1-22
Author(s):  
Gale Julie ◽  
Steven James ◽  
Wayne Varndell ◽  
Lin Perry
2017 ◽  
Vol 20 (1) ◽  
pp. 69-73 ◽  
Author(s):  
Kei Ouchi ◽  
Susan D. Block ◽  
Mara A. Schonberg ◽  
Emily S. Jamieson ◽  
Emily L. Aaronson ◽  
...  

2019 ◽  
Vol 21 (1) ◽  
pp. 39-52
Author(s):  
George J.E. Crowther ◽  
Cathy A. Brennan ◽  
Katherine L.A. Hall ◽  
Abigail J. Flinders ◽  
Michael I. Bennett

Purpose People with dementia in hospital are susceptible to delirium, pain and psychological symptoms. These diagnoses are associated with worse patient outcomes, yet are often underdiagnosed and undertreated. Distress is common in people experiencing delirium, pain and psychological symptoms. Screening for distress may therefore be a sensitive way of recognising unmet needs. The purpose of this paper is to describe the development and feasibility testing of the Distress Recognition Tool (DRT). The DRT is a single question screening tool that is incorporated into existing hospital systems. It encourages healthcare professionals to regularly look for distress and signposts them to relevant resources when distress is identified. Design/methodology/approach The authors tested the feasibility of using the DRT in people with dementia admitted on two general hospital wards. Mixed methods were used to assess uptake and potential mechanisms of impact, including frequency of use, observation of ward processes and semi-structured interviews with primary stakeholders. Findings Over a 52-day period, the DRT was used during routine care of 32 participants; a total of 346 bed days. The DRT was completed 312 times; an average of 0.9 times per participant per day. Where participants had an identified carer, 83 per cent contributed to the assessment at least once during the admission. Thematic analysis of stakeholder interviews, and observational data suggested that the DRT was quick and simple to complete, improved ward awareness of distress and had the potential to improve care for people with dementia admitted to hospital. Originality/value This is the first short screening tool for routinely detecting distress in dementia in any setting. Its uptake was positive, and if effective it could improve care and outcomes for people with dementia, however it was beyond the scope of the study test this.


2017 ◽  
Vol 4 (9) ◽  
pp. 2878
Author(s):  
Madhivadhanam Parasuraman ◽  
Bhanumati Giridharan ◽  
G. Vijayalakshmi

Diabetes is the common cause for amputation of lower limb. Foot ulcers and associated complications are important causes of mortality and morbidity in patients with diabetes. Hence, it is important to predict diabetic foot ulcer in its early stages to eliminate the risks of foot amputation. Inlow’s 60 second diabetic foot ulcer screening tool is gaining immense attention over the years which is associated with its simplicity to use, rapid detection of high risk diabetic feet, and provides referral for patients necessitating treatment. A systematic review is conducted to assess the reliability and credibility of using Inlow’s 60 second diabetic foot screening tool for diabetic foot risk stratification and to examine its feasibility in the Indian context. Eight studies suited the inclusion criteria which were analysed systematically. The findings of the paper reveal that the sixty second tool acts as a better tool for diabetic foot ulcer risk stratification; however, modifications are necessary for its application in the Indian context.


2018 ◽  
Vol 9 (8) ◽  
pp. 373-384 ◽  
Author(s):  
Lynn Gers ◽  
Mirko Petrovic ◽  
Stany Perkisas ◽  
Maurits Vandewoude

Objectives: Antidepressant use increases as age rises. Moreover, older patients are more sensitive to side effects and drug interactions. This descriptive study aims to map antidepressant use among patients at the geriatrics department of a university hospital and to evaluate whether prescribing happens in an evidence-based manner. Methods: Patients aged 75 years and over, admitted to the geriatrics department of the Middelheim Hospital in Antwerp between February and July 2017 were included. We checked whether they took antidepressants, which types and doses were prescribed, who prescribed the antidepressants, and whether prescribing was in concordance with the revised STOPP (Screening Tool of Older People’s Prescriptions) criteria. Results: Out of the 239 included patients, 61 were found to use antidepressants, with depression being the most important indication. General practitioners appeared to be the most frequent prescribers. Trazodone was the most prescribed antidepressant and was often used for sleeping disorders. Antidepressants were taken longer than recommended in almost one out of five cases. Patients with diabetes and renal insufficiency were prescribed antidepressants less frequently. Only 2.8% of the study participants were prescribed antidepressants for anxiety disorders. Conclusion: We can conclude that prescription of antidepressants in older patients at the geriatrics department is often not evidence based. Clear guidelines may offer a solution; therefore more studies are needed on antidepressant use in older patients.


2017 ◽  
Vol 20 (4) ◽  
pp. 270-278 ◽  
Author(s):  
Gagik R. Galstyan ◽  
Ekaterina A. Shestakova ◽  
Igor A. Sklyanik

Type 2 diabetes and obesity are two enormous epidemic diseases of the 21stcentury. Because obesity is a primary risk factor for type 2 diabetes development, patients with diabetes are frequently obese. This comorbidity makes it challenging for these patients to not only compensate diabetes but also bring their weight back to normal. Several anti-diabetic drugs cause weight gain, which augments insulin resistance, and thus demands anti-diabetic treatment intensification. For the treatment, it is crucial to find an anti-diabetic treatment drug that is efficient but does not cause weight gain. In the last few decades, new anti-diabetic drugs with minimal or decrementing effects on the body weight have been introduced. New molecules appearing in the anti-obesity treatment are capable of not only reducing weight but also compensating diabetes. This study focuses on the current anti-obesity and anti-diabetic treatment and optimal combinations for treating comorbid patients.


2010 ◽  
Vol 9 (1) ◽  
pp. 26 ◽  
Author(s):  
Giselle L Ferrari ◽  
Jefferson LB Marques ◽  
Rajiv A Gandhi ◽  
Simon R Heller ◽  
Fábio K Schneider ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document